SCHEMBL26324980

SCHEMBL26324980

Cc1cc(C)cc(N(c2cccc(-c3ccccc3)c2)C(C(=O)OC(C)C)C(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
MMP2 P08253 4/20 0.36
MMP9 P14780 4/20 0.36
MMP3 P08254 2/20 0.36
MMP8 P22894 2/20 0.36
MMP12 P39900 2/20 0.36
MMP13 P45452 2/20 0.36
MMP14 P50281 2/20 0.36
MMP16 P51512 2/20 0.36
FFAR1 O14842 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXRA P19793 2/20 0.35
RXRB P28702 2/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26325013 0.93 PDCD1 (0.44) PDCD1CD274MMP2MMP9MMP3
SCHEMBL25440020 0.88 PDCD1 (0.40) PDCD1CD274HSD17B1HSD17B2FFAR1
SCHEMBL26324955 0.82 PDCD1 (0.50) PDCD1CD274MMP2MMP9MMP3
SCHEMBL26324974 0.81 PTGS1 (0.39) HSD17B1HSD17B2MMP2MMP9MMP3
SCHEMBL26325014 0.81 PDCD1 (0.51) PDCD1CD274MMP2MMP9MMP3
SCHEMBL26324800 0.80 TSHR (0.42) PDCD1CD274MMP2MMP9MMP3
SCHEMBL26324953 0.80 HSD17B1 (0.40) HSD17B1HSD17B2HTTMAPTKMT2A
SCHEMBL25439930 0.79 PDCD1 (0.46) PDCD1CD274FFAR1RXRARXRB
SCHEMBL26324940 0.79 TRPM8 (0.39) PDCD1CD274MMP2MMP9MMP8
SCHEMBL26324981 0.78 MEN1 (0.38) LMNASMN1; SMN2MAPTKMT2AMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 PDCD1 3686/4885CD274 4128/4885HSD17B1 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.